celgarten

Pediatric Oncology and Stem Cell Transplant physician at @childrensphila focused on infectious supportive care

[celgarten @celgarten]

@hannahrwardill Terrific work @hannahwardill

[celgarten @celgarten]

Nice work by @AdamEsbenshade A step toward avoiding unnecessary antibiotics in this population. @Supp_Care4Kids

[Adam Esbenshade MD, MSCI @AdamEsbenshade]

Thank you to all my co-authors for this outstanding collaboration! @DrPHO_ID @Joshuawolf @Jen_WilkesMD @Jennifer_Belsky @JennaDemedis @DanielRuncoMD @Nate_Nessle @gabhaeusler @reginamyersmd @tpmiller12 @mayabasbous @BeckyRichardsMD @DrJessicaSheth @celgarten

[Wolpawlab @wolpawlab]

Interested in childhood cancer? In vivo models of immunotherapy response? Collaborative science? Come join my and Kris Bosse's labs at the Children's Hospital of Philadelphia - email me at [email protected] or apply here https://t.co/mFS51wxBd9.

[Ahmed M. Moustafa @Ahmed_Microbes]

The CHOP Microbiome Center is #hiring Administrative Manager. Know anyone who might be interested?
Join the #1 Forbes America's Best Large Employer @ChildrensPhila @CHOP_Research @PCMicrobiome
https://t.co/Vo7RteTbbH
Please retweet!

[celgarten @celgarten]

@kmcnern3 describes carHLH in a real world pediatric ALL cohort at #Tandem22. Outcomes poor for this group but more work needed to understand interventions that could mitigate.

[Infection Control & Hospital Epidemiology @ICHEJournal]

New from @celgarten et al

➡️In contrast to other populations, for pediatric AML patients, CVAD type does not alter risk of bacterial BSI during neutropenia.

➡️Unique pathophysiology of BSI in this patient population may be responsible.

📄: https://t.co/jc5KciOSXi

[celgarten @celgarten]

Education + CPOE can improve guideline concordant CINV prophylaxis prescribing. @CarolineDiorio’s paper describing this QI project is out and the pathway is publicly available https://t.co/4qkt3pzwCO @jasonfreedmanmd @Supp_Care4Kids

[celgarten @celgarten]

Intensifying induction 2 chemotherapy did not improve outcomes on the COG backbone. We need better therapies for children and adolescents with high risk AML https://t.co/F0Cc2FVe2U

[DMarc @Dweb84]

A gofundme for two great friends in south Philly. They also make the best croissants in the country, Big statement but no doubt in my mind
#fcancer #GoFundMe

https://t.co/IAmDRWVMuM

[celgarten @celgarten]

@bethmcm Well at least today there was some confusion from the oncologists too 🤪

[Dr. Glaucomflecken @DGlaucomflecken]

The easy residency

[Lindsey A. George (UPENN & CHOP) @LindseyAGeorge]

Looking for another post doc to join us! Exciting work in the molecular basis of coagulation focusing on FVIII and hemophilia A gene therapy.

https://t.co/eBZMqrUU60

[Abby Rosenberg, MD, MS, MA @AbbyRosenbergMD]

Cancer center leadership does not reflect our workforce or our patient population.

Leadership teams with women were more likely to be representative of race, ethnicity, and gender.

More evidence that leadership needs to look like it’s constituency. https://t.co/DsWoEOT0Dn

[Yang Ding, MD @YangDing19]

Very excited to share our work describing a systems biology approach to finding new therapeutic targets in a high risk leukemia subtype. Truly synergistic teamwork with @KaiTanLab1 and Tasian lab colleagues! @CCR_AACR https://t.co/TlOdT50N0Z

[Jessica Foglesong MD 👩🏻‍⚕️ @foglesong_md]

Why not, #bmtsm #pedspmt @xkcd_rss

[PedsHemeDoc @PedsHemeDoc]

This visual abstract is genius!

A pediatric heme/onc version, I'm sure there's more we can add 🤣😭🤣... #PHOdocs

[Atul Gawande @Atul_Gawande]

We have gone big to vaccinate the US. We need to undertake exactly such an effort abroad: an all-out response for an all-in global vaccination campaign.

We have the production know-how, the logistics expertise, and the ability to rally the world.
https://t.co/tIN4nXNqkI

[Laura Vella @LauraVella17]

Excited to see our work interrogating this new syndrome published and proud of the group effort here with @facts___matter @amylizbaxter @OldridgeDerek and many others @Penn_IFI and @CHOP_Research. Deep immune profiling of MIS-C https://t.co/lP2CNGpfzz.